Amgen convinced a federal judge in Delaware on Thursday to invalidate two patents owned by Lindis Biotech, undercutting a $50.3 million jury verdict Lindis won last year in an infringement lawsuit ...

The first day of deliberations saw a flurry of notes from the jury and Combs and his supporters bowing their heads in prayer in the courtroom.

The new ruling reverses a jury verdict from four years ago that handed ArcherDx, which no longer exists, $4.7 million in damages.